Psychiatry and Mental health papers
Pofolia’s corpus holds 106 papers from Psychiatry and Mental health (1999–2026), each with a short summary. Below, the 20 most-cited, then the most recently added.
At a glance
- Most cited: The Effect of Riding as an Alternative Treatment for Children with Cerebral Palsy: A Systematic Review and Meta-Analysis (2015, 18,699 citations).
- The 20 papers listed have 135,903 citations between them.
- 14 of the 16 with a known journal quartile appeared in a Q1 journal.
- 12 have a free full text (open access).
- Most frequent journals: Alzheimer s & Dementia, Epilepsia, Cephalalgia.
- Published between 1999 and 2023.
Most cited
Ranked by citation count. Because citations accumulate over time, this list naturally leans towards work published a few years ago; for where the field is now, see “recently added”. How to read the signals
The Effect of Riding as an Alternative Treatment for Children with Cerebral Palsy: A Systematic Review and Meta-Analysis
Integrative Medicine International · 2015 · FWCI 176.39 · 18,699 citations · Open access
Hippotherapy, therapeutic horse riding, and artificial saddle use significantly improve gross motor function in children with cerebral palsy, particularly in walking, running, and jumping.
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
The Lancet · 2017 · FWCI 1019.99 · 13,573 citations · Open access
Globally, the total number of years lived with disability (YLDs) decreased by 2.7% from 1990-2016, but the absolute number of YLDs from non-communicable diseases is rapidly increasing due to aging populations. Low back pain, migraine, and hearing loss were the leading causes of YLDs in 2016.
Pharmacological interventions for somatoform disorders in adults
Cochrane Database of Systematic Reviews · 2014 · FWCI 476.92 · 11,360 citations
This systematic review found very low-quality evidence that new-generation antidepressants (NGAs) may reduce the severity of medically unexplained physical symptoms (MUPS) in adults with somatoform disorders. Low-quality evidence also suggests natural products may be effective.
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Cephalalgia · 2018 · Q1 · SJR 1.00 · FWCI 552.95 · 10,592 citations · Open access
The International Headache Society (IHS) has released the 3rd edition of the International Classification of Headache Disorders (ICHD-3). This updated classification system provides a standardized framework for diagnosing and categorizing headache disorders.
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Alzheimer s & Dementia · 2018 · Q1 · SJR 4.00 · FWCI 497.34 · 10,499 citations · Open access
A new research framework defines Alzheimer's disease (AD) by its underlying pathology, using biomarkers like amyloid and tau (ATN), rather than clinical symptoms.
Mild Cognitive Impairment
Archives of Neurology · 1999 · FWCI 51.80 · 9,031 citations
Subjects with Mild Cognitive Impairment (MCI) show memory deficits beyond age expectations but are not demented, distinguishing them from healthy controls and mild Alzheimer's Disease (AD) patients.
The International Classification of Headache Disorders, 3rd edition (beta version)
Cephalalgia · 2013 · Q1 · SJR 1.00 · FWCI 405.71 · 8,241 citations · Open access
This paper presents the beta version of the 3rd edition of the International Classification of Headache Disorders (ICHD-3 beta). It serves as a preliminary update to the diagnostic criteria for headache disorders.
ILAE Official Report: A practical clinical definition of epilepsy
Epilepsia · 2014 · Q1 · SJR 2.00 · FWCI 153.14 · 5,953 citations
The International League Against Epilepsy (ILAE) has updated the practical definition of epilepsy to include individuals with one unprovoked seizure and a high recurrence risk (>=60% over 10 years), or a diagnosed epilepsy syndrome.
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
The Lancet Public Health · 2022 · Q1 · SJR 8.00 · FWCI 617.78 · 5,239 citations · Open access
The global number of dementia cases is projected to nearly triple from 57.4 million in 2019 to 152.8 million by 2050, driven primarily by population growth and aging.
2016 Alzheimer's disease facts and figures
Alzheimer s & Dementia · 2016 · Q1 · SJR 4.00 · FWCI 551.02 · 5,109 citations
Alzheimer's disease is a growing public health crisis, with an estimated 5.4 million Americans currently affected and projected to reach 13.8 million by mid-century. Deaths from Alzheimer's increased 71% between 2000 and 2013, contrasting with decreases in deaths from other major diseases.
The global prevalence of dementia: A systematic review and metaanalysis
Alzheimer s & Dementia · 2013 · Q1 · SJR 4.00 · FWCI 48.22 · 4,933 citations
Globally, 35.6 million people lived with dementia in 2010, with prevalence ranging from 5-7% in most regions, but notably lower in sub-Saharan Africa (2-4%) and higher in Latin America (8.5%).
ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology
Epilepsia · 2017 · Q1 · SJR 2.00 · FWCI 227.71 · 4,917 citations · Open access
The International League Against Epilepsy (ILAE) has released an updated classification system for epilepsies, reflecting recent scientific advances and incorporating etiology at each diagnostic level.
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
New England Journal of Medicine · 2012 · Q1 · SJR 18.00 · FWCI 131.51 · 3,848 citations
In autosomal dominant Alzheimer's disease, key pathological changes begin decades before symptom onset, with amyloid-beta levels dropping 25 years prior and brain metabolism impairment appearing 10 years before.
Interplay between Cortical Spreading Depolarization and Seizures
Stereotactic and Functional Neurosurgery · 2017 · Q2 · FWCI 164.05 · 3,708 citations · Open access
This paper clarifies the complex, bidirectional relationship between cortical spreading depolarization (CSD) and seizures, suggesting CSD may synchronize brain tissue, potentially favoring seizure activity.
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
Molecular Psychiatry · 2021 · Q1 · SJR 4.00 · FWCI 120.54 · 3,665 citations · Open access
Globally, 62.5% of individuals experience the onset of any mental disorder by age 25, with a peak onset age of 14.5 years, according to a meta-analysis of 192 studies involving over 700,000 people.
Cognitive Stimulation in Patients with Dementia: Randomized Controlled Trial
Dementia and Geriatric Cognitive Disorders Extra · 2013 · Q3 · FWCI 134.85 · 3,465 citations · Open access
A newly developed Geriatric Depression Scale (GDS) demonstrates strong reliability and validity for assessing depression in the elderly, outperforming the Zung Self-Rating Depression Scale (SDS).
Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology
Epilepsia · 2017 · Q1 · SJR 2.00 · FWCI 170.66 · 3,399 citations · Open access
The International League Against Epilepsy (ILAE) has released a revised operational classification for seizure types, introducing more transparent terminology and allowing for classification when seizure onset is unobserved.
2013 Alzheimer's disease facts and figures
Alzheimer s & Dementia · 2013 · Q1 · SJR 4.00 · FWCI 204.50 · 3,337 citations
Alzheimer's disease (AD) is a growing public health crisis, with an estimated 5.2 million Americans currently affected and a new case developing every 68 seconds. The proportion of deaths from AD increased by 68% between 2000 and 2010, significantly outpacing declines in deaths from heart disease, stroke, and prostate cancer.
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Alzheimer s & Dementia · 2012 · Q1 · SJR 4.00 · FWCI 77.84 · 3,192 citations · Open access
Updated guidelines for neuropathologic assessment of Alzheimer's disease (AD) now incorporate amyloid accumulation alongside neurofibrillary changes and neuritic plaques, and recognize a pre-clinical stage of AD.
2023 Alzheimer's disease facts and figures
Alzheimer s & Dementia · 2023 · Q1 · SJR 4.00 · FWCI 572.32 · 3,143 citations
Alzheimer's disease is a growing public health crisis, with an estimated 6.7 million Americans currently affected and projected to reach 13.8 million by 2060 without breakthroughs. Deaths from Alzheimer's increased over 145% between 2000 and 2019, and the disease remains a leading cause of death.
Recently added
Older Adults’ Perceived Barriers to Non-Joining Community-Based Cognitive Stimulation Programs: A Qualitative Study
Ageing International · 2026 · Q2
Older adults perceive barriers related to program design, social concerns, and resistance to change as reasons for not joining community-based cognitive stimulation programs.
Pathogenic NLGN4X variants reveal dual roles in synaptic connectivity and cortical development
Translational Psychiatry · 2026 · Q1 · SJR 2.00
Pathogenic NLGN4X variants (G243R and others in aa 235-245) cause severe protein trafficking defects, impairing cell surface localization, synaptogenesis, and neuronal migration, offering mechanistic insight into neurodevelopmental disorders.
Neighbourhood-level variations in psychosis prevalence and involuntary psychiatric admissions
Schizophrenia Research · 2026 · Q1 · SJR 1.00
Psychosis prevalence and involuntary admissions show geographical clustering in South London, with higher prevalence linked to deprivation, population density, social fragmentation, minoritised ethnic backgrounds, and crime, and lower prevalence in areas with more green space.
Is methylphenidate truly cardiac-safe? Insight from biventricular speckle tracking echocardiography in pediatric patients with attention deficit hyperactivity disorder
European Journal of Pediatrics · 2026 · Q1
Methylphenidate (MPH) treatment in pediatric ADHD patients led to subclinical reductions in both systolic and diastolic cardiac function, detectable by speckle tracking echocardiography but not conventional methods.
FEEDSETUP: feeding difficulties spectrum evaluation and treatment up-to-date proposal
Jornal de Pediatria · 2026 · Q1
A new framework, FEEDSETUP, offers a stepwise, multidisciplinary approach to pediatric feeding difficulties, matching intervention intensity to clinical need and severity.
Weight Gain Goals and Factors Associated With Readmission for Faltering Weight in Infants
Hospital Pediatrics · 2026 · Q1
Infants meeting registered dietitian (RD) weight gain goals, especially those exceeding WHO standards, had 70% lower readmission rates for faltering weight (OR 0.30; n=273).
Sexual health and healthy aging: the five ‘I’s conceptual framework
Sexual Health · 2026 · Q2
The five 'I's framework (importance, individuality, inclusion, involvement, integration) provides a practical approach to enhance sexual health services, research, and policy for older adults.
Cerebellar cortical amyloid deposition biases 18F-Florbetapir PET quantification with whole cerebellum as reference region
European Journal of Nuclear Medicine and Molecular Imaging · 2026 · Q1 · SJR 2.00 · Open access
Amyloid-beta (Aβ) deposition in the cerebellar cortex biases 18F-Florbetapir PET scans, leading to underestimation of cerebral Aβ burden when the whole cerebellum is used as a reference region.
Journals in this field
The journals that publish most of this field’s papers. Quartile (Q1–Q4), SJR and h-index are from SCImago Journal Rank; “in this field” is how many of the journal’s pooled papers belong here. What is a Q1 journal? · What is the h-index?
| Journal | Quartile | SJR | h-index | In this field | Summaries |
|---|---|---|---|---|---|
| Alzheimer's and Dementia | Q1 | 4.00 | 194 | 16 | 19 |
| JAMA | Q1 | 5.00 | 818 | 5 | 114 |
| New England Journal of Medicine | Q1 | 18.00 | 1275 | 4 | 376 |
| JAMA Psychiatry | Q1 | 5.00 | 429 | 4 | 15 |
| Epilepsia | Q1 | 2.00 | 240 | 4 | 4 |
| Neurology | Q1 | 2.00 | 435 | 3 | 12 |
| The Lancet Neurology | Q1 | 12.00 | 398 | 2 | 12 |
| The Lancet Public Health | Q1 | 8.00 | 123 | 2 | 13 |
Every journal in Psychiatry and Mental health (Q1–Q4) →
Add this field to your daily feed
Pick your interests and new work in your area arrives every day, summarised. Full summaries live in the app.
Open the app